DexCom Inc (DXCM)

524.43
+4.94(+0.95%)
After Hours
524.43
0.00(0.00%)
- Real-time Data
  • Volume:
    1,046,167
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    510.49 - 530.60

DXCM Overview

Prev. Close
519.49
Day's Range
510.49-530.6
Revenue
2.32B
Open
517.59
52 wk Range
318.45-659.45
EPS
5.32
Volume
1,046,167
Market Cap
50.83B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
593,406
P/E Ratio
98.59
Beta
0.81
1-Year Change
50.69%
Shares Outstanding
96,922,034
Next Earnings Date
Feb 23, 2022
What is your sentiment on DexCom Inc?
or
Market is currently closed. Voting is open during market hours.

  • Is DexCom Setting Up for a Breakout?
    • ByStockNews-

    A bullish flag pattern has emerged in the chart of Dexcom Inc. (NASDAQ:DXCM), where the stock is just under a resistance line. If DXCM breaks through this level, a breakout could...

  • Wells Fargo Stick to Their Hold Rating for Dexcom
    • ByInvesting.com-

    Wells Fargo (NYSE:WFC) analyst Larry Biegelsen maintained a Hold rating on Dexcom (NASDAQ:DXCM) on Friday, setting a price target of $475, which is approximately 4.16% above the...

DexCom Inc Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy
  • Breakinf anothe ATH- promising
    0
    • silently but keeps rising and rising....
      0
      • dexcom more catalysts to come pls...... long term investors
        0
        • great ernings
          0
          • slm
            0
          • yaharkar takene
            0
        • DEXCOM BUY AT 430 SL 412 TGT 455.80
          0
          • DAY high DEX COM 445🚀🚀🚀
            0
        • Look senseonics stock, it ll be huge in a few months!!!!
          0
          • about Dexcom
            0
            • What about it? Haha
              0
            • Diligent Investorsir can u help me plez
              0
          • If you like this stock then look at SENS.... really good entry point
            1
            • it will.come.to 300
              0
              • Up from here 500 target $$$
                0
                • Do you think? Since June, I've had Vuzix, Paycom and Solaredge all perform extremely well. Dexcom has been a laggard. I was thinking of dumping it and getting Lemonade.
                  2
              • Great outcome for 2Q, it will rise tremendously tomorrow
                0
                • It wi go up next week
                  0
                  • I just bought. Good price. Earnings will be good as usual. This will continue to go up. Long term
                    0
                    • I'll buy this again at 350
                      0
                      • Why sharply down
                        0
                        • quick squeeze
                          0
                          • This thing is crashing. $200 next.
                            8
                            • Based on what?
                              0
                            • David Garcia It was a typo. I meant to say it will crash to $300. Lots of people are selling since the economy is opening back up.
                              0
                            • $300 wouldn’t be a bad entry point..
                              0
                          • lol used to own at $60/share cant believe I sold them all at 85
                            0
                            • Unbelievable. How many shares did you have?
                              0
                            • Bruce Wayne lol like 2k worth. back in 2013/14.
                              0
                            • Ooooooo Weeeeee there are other stocks with similar percentage, I have a bunch (5000 shares) with SYNH, so far 70% gains since Mar23
                              0
                          • I'm diabetic and this company has the technology of the future.
                            0
                            • I heard the same from a diabetic friend. She loves the company. I took some profits after I made 60%, after others started taking profits too.
                              0
                          • Bubble. 370 next
                            5
                            • 600
                              0
                              • Dexcom rules, now the pump made by Tandem, that will be the next one
                                0
                                • My grandson was recently diagnosed with T1 Diabetes. After sticking himself dozens of times per day to get sugar numbers, he now has the DEXCOM sensor. After four weeks the results are phenomenal. The meter gives a new number every five minutes. Very accurate. No sticks anymore. A wonderful product.
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.